<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04340817</url>
  </required_header>
  <id_info>
    <org_study_id>Flinc07042020</org_study_id>
    <nct_id>NCT04340817</nct_id>
  </id_info>
  <brief_title>Fatty Liver Disease in Nordic Countries</brief_title>
  <acronym>FLINC</acronym>
  <official_title>Fatty Liver Disease in Nordic Countries (FLINC): a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Copenhagen University Hospital, Hvidovre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Copenhagen University Hospital, Hvidovre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective cohort study, which aims to systematically evaluate biomarkers and potential
      targets in NAFLD and NASH.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fibrosis</measure>
    <time_frame>5 years</time_frame>
    <description>Number of participants with fibrosis proression</description>
  </primary_outcome>
  <enrollment type="Anticipated">634</enrollment>
  <condition>Non-Alcoholic Fatty Liver Disease</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Proteomics</intervention_name>
    <description>Mass-spectometry proteomics</description>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Transcriptomics</intervention_name>
    <description>Next generation sequencing</description>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Genomics</intervention_name>
    <description>Targeted genetics</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, serum, buffy coat, liver tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The investigators plan to include patients with suspected or verified non-alcoholic fatty
        liver disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-alcoholic fatty liver disease and

          -  Healthy volunteers

        Exclusion Criteria:

          -  Other liver diseases than non-alcoholic fatty liver disease

          -  Lack of informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lise L Gluud, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Copenhagen University Hospital Hvidovre, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lise L Gluud, MD</last_name>
    <phone>+45 38623862</phone>
    <email>lise.lotte.gluud.01@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mikkel P Werge, MD</last_name>
    <phone>+45 38623862</phone>
    <email>Mikkel.parsberg.werge@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gastrounit, Copenhagen University Hospital Hvidovre</name>
      <address>
        <city>Hvidovre</city>
        <state>Capital Region Denmark</state>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise L Gluud, MD</last_name>
      <phone>+4538621964</phone>
      <email>lise.lotte.gluud.01@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Mikkel P Werge, MD</last_name>
      <phone>+38620411</phone>
      <email>mikkel.parsberg.werge@regionh.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 7, 2020</study_first_submitted>
  <study_first_submitted_qc>April 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2020</study_first_posted>
  <last_update_submitted>April 9, 2020</last_update_submitted>
  <last_update_submitted_qc>April 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Copenhagen University Hospital, Hvidovre</investigator_affiliation>
    <investigator_full_name>Lise Gluud</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

